Phathom Pharmaceuticals Inc to Discuss The FDA Approval Transcript
Welcome to the Phathom Pharmaceuticals FDA Approval Conference Call. (Operator Instructions) Please be advised that today's call is being recorded. With that, I would like to turn the conference call over to Eric Sciorilli, Head of Investor Relations. Please go ahead.
Thank you, operator. Hello, everyone, and thank you all for joining us this morning to discuss our recent FDA approvals. Just a couple of logistical items before we get started. A recording of today's webcast and presentation can be found under the Events and Presentations section of our corporate website. Also, before we begin, let me remind you that we will be making a number of forward-looking statements throughout today's presentation. These forward-looking statements involve risks and uncertainties, many of which are beyond Phathom's control. Actual results can materially differ from the forward-looking statements, and any such risks can materially adversely affect the business, the results of operations and trading prices for Phathom's common stock. For a detailed description of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
